Fresenius SE & Co. KGaA



 


Participations

Major affiliated companies of the Fresenius Group
(as of May 2013)

held by Fresenius in %

Germany
31%
Fresenius Medical Care AG & Co. KGaA
Hof an der Saale
share of votes 30.77%
100%
Fresenius Kabi Deutschland GmbH
Bad Homburg v.d.H.
100%
Fresenius HemoCare GmbH
Bad Homburg v.d.H.
100%
HELIOS Group
Berlin
Italy
100%
Fresenius Kabi Italia S.p.A.
Verona
100%

Fresenius Kabi Anti-Infectives S.r.l.
Cernusco sul Naviglio

Spain
100%
Fresenius Kabi España S.A.U.
Barcelona
France
100%
Fresenius Kabi France S.A.S.
Sèvres
100%
Fresenius Vial S.A.S.
Brézins
Great Britain
100%
Fresenius Kabi Ltd.
Runcorn/Cheshire
Austria
100%
Fresenius Kabi Austria GmbH
Graz
77%
VAMED-Group
Vienna
Switzerland
100%
Fresenius Kabi (Schweiz) AG
Oberdorf NW
Netherlands
100%
Fresenius Kabi Nederland B.V.
's-Hertogenbosch
100%
Fresenius HemoCare Netherlands B.V.
Emmen
Belgium
100%
Fresenius Kabi N.V.
Schelle
Norway
100%
Fresenius Kabi Norge A/S
Halden
Sweden
100%
Fresenius Kabi AB
Stockholm
Poland
100%
Fresenius Kabi Polska Sp. z.o.o
Warsaw
Portugal
100%
Labesfal - Laboratórios Almiro S.A.
Campo de Besteiros
Mexico
100%
Fresenius Kabi Méxiko S.A. de C.V.
Guadalajara
Brazil
100%
Fresenius Kabi Brasil Ltda.
São Paulo

100%

Fresenius HemoCare Brasil Ltda.
São Paulo
Chile

100%

Laboratorio Sanderson S.A.
Santiago de Chile
Colombia
100% Fresenius Kabi Colombia S.A.S.
Bogota D.C.
China
51%
Sino-Swed Pharmaceutical Corporation Ltd.
Wuxi
100%
Beijing Fresenius Pharmaceutical Co., Ltd.
Beijing
Korea
100%
Fresenius Kabi Korea Ltd.
Seoul
Malaysia
100% Fresenius Kabi Malaysia Sdn. Bhd.
Kuala Lumpur
Thailand
100% Fresenius Kabi (Thailand) Ltd.
Bangkok
Vietnam
 73% Fresenius Kabi Bidiphar JSC
Quy Nhon
Australia
100%
Fresenius Kabi Australia Pty Ltd.
Sydney
South Africa
100%
Fresenius Kabi South Africa (Pty) Ltd.
Midrand
Canada
100%
Calea Ltd.
Toronto
USA
100%
Fresenius Kabi Pharmaceuticals Holding, Inc.
Wilmington/Delaware

 100%

Fenwal, Inc.
Wilmington/Delaware
India
81%
Fresenius Kabi Oncology Ltd.
New Delhi